5.00
-0.3(-5.66%)
Currency In USD
| Previous Close | 5.3 |
| Open | 5.3 |
| Day High | 5.33 |
| Day Low | 4.84 |
| 52-Week High | 81 |
| 52-Week Low | 4.75 |
| Volume | 249,674 |
| Average Volume | 179,621 |
| Market Cap | 11.65M |
| PE | -0.04 |
| EPS | -138 |
| Moving Average 50 Days | 12.61 |
| Moving Average 200 Days | 30.27 |
| Change | -0.3 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $81.3 as of February 05, 2025 at a share price of $5. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $8.01 as of February 05, 2025 at a share price of $5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Announces Effective Date of Reverse Stock Split
GlobeNewswire Inc.
Jan 22, 2025 9:05 PM GMT
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-60. The effective time of th
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss
GlobeNewswire Inc.
Jan 14, 2025 1:00 PM GMT
OGM uniquely identified a complex chromosomal rearrangement missed by classical cytogenetics, helping clinical researchers apply targeted screening to select the most fit embryos for transferFollowing in-vitro fertilization, preimplantation genetic t
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
GlobeNewswire Inc.
Jan 13, 2025 1:00 PM GMT
Preliminary Q4 2024 revenue expected to be between $7.9 and $8.1 million, which would represent an estimated decrease of approximately 25% over Q4 2023 due primarily to discontinuation of clinical service products in 2024Installed base of optical gen